Zhou Wenyong, Wang Shaohua, Yang Jichun, Shi Qi, Feng Nana, Gao Kaiheng, Posum Wan, Shi Mengkun, Xiang Meng, Shi Meng
Department of Thoracic and Cardiovascular Surgery, Huashan Hospital, Affiliated to Fudan University, Shanghai, China.
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Int J Surg. 2025 Feb 1;111(2):1874-1890. doi: 10.1097/JS9.0000000000002217.
Pulmonary ischemia-reperfusion injury (PIRI) is a major cause of fatality post-lung transplantation. Though some long non-coding RNAs (lncRNAs) have been studied in acute lung injury (ALI), their effects on PIRI remain undefined. The present study aims to explore the underlying mechanism of small nucleolar RNA host gene 16 (SNHG16) in PIRI.
PIR mouse and oxygen-glucose deprivation/reoxygenation (OGD/R) cell models were established. Exosomes were extracted from human pulmonary microvascular endothelial cells (HPMECs). Functional and rescue experiments were conducted in OGD/R-exposed HPMECs, OGD/R-exposed pulmonary alveolar epithelial type II cells (AECs), and I/R model mice. The relationships among SNHG16, miR-372-3p/miR-373-3p, and MTCH2 were also verified using dual luciferase reporter assay, RNA pull-down and RIP assay.
SNHG16 was downregulated in OGD/R-exposed HPMECs, and SNHG16 overexpression accelerated proliferation, angiogenesis, and ameliorated mitochondrial respiration in OGD/R-exposed HPMECs. HPMEC-derived exosomal SNHG16 suppressed OGD/R-induced type II AEC injury. SNHG16 ameliorated lung injury in PIR mice. Mechanistically, SNHG16 targeted and negatively regulated miR-372-3p and miR-373-3p expression, and MTCH2, a target gene of miR-372-3p/miR-373-3p. SNHG16 was found to upregulate MTCH2 expression not only in a miR-372-3p and miR-373-3p-dependent manner but also suppress ubiquitination induced MTCH2 degradation.
Our findings revealed that SNHG16 overexpression suppressed OGD/R-induced HPMEC apoptosis by promoting Warburg effect, and HPMEC-derived exosomal SNHG16 alleviated PIRI through the miR-372-3p/miR-373-3p/MTCH2 axis, suggesting that SNHG16 as a therapeutic target for PIRI.
肺缺血再灌注损伤(PIRI)是肺移植术后死亡的主要原因。尽管一些长链非编码RNA(lncRNAs)已在急性肺损伤(ALI)中得到研究,但其对PIRI的影响仍不明确。本研究旨在探讨小核仁RNA宿主基因16(SNHG16)在PIRI中的潜在机制。
建立PIR小鼠和氧糖剥夺/复氧(OGD/R)细胞模型。从人肺微血管内皮细胞(HPMECs)中提取外泌体。在暴露于OGD/R的HPMECs、暴露于OGD/R的肺泡Ⅱ型上皮细胞(AECs)和I/R模型小鼠中进行功能和挽救实验。还使用双荧光素酶报告基因检测、RNA下拉和RIP检测验证了SNHG16、miR-372-3p/miR-373-3p和MTCH2之间的关系。
在暴露于OGD/R的HPMECs中SNHG16表达下调,SNHG16过表达可促进暴露于OGD/R的HPMECs的增殖、血管生成并改善线粒体呼吸。HPMEC来源的外泌体SNHG16可抑制OGD/R诱导的Ⅱ型AEC损伤。SNHG16可改善PIR小鼠的肺损伤。机制上,SNHG16靶向并负调控miR-372-3p和miR-373-3p的表达,以及miR-372-3p/miR-373-3p的靶基因MTCH2。发现SNHG16不仅以miR-372-3p和miR-373-3p依赖的方式上调MTCH2表达,还抑制泛素化诱导的MTCH2降解。
我们的研究结果表明,SNHG16过表达通过促进瓦伯格效应抑制OGD/R诱导的HPMEC凋亡,HPMEC来源外泌体SNHG16通过miR-372-3p/miR-373-3p/MTCH2轴减轻PIRI,提示SNHG16可作为PIRI的治疗靶点。